Use access key #2 to skip to page content.
$2.92 -0.01 (-0.34%)
7/24/2008 9:43 AM

MannKind Corp (MNKD)

CAPS Rating:
**

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

View All Commentary (MNKD)

Recs

0

Avatar Afropuffashion (< 20) Submitted: 5/07/08 2:58 PM : Underperform Start Price: $2.45 MNKD Score: -28.00

Zack's Analyst blog said the company has sunk over a billion dollars into a controversial drug. The earliest the drug can be release is 2011. His recommendation-Sell to $1.50





http://www.blackenterprise.com/yb/ybopen.asp?section=ybin&st...

Report this Post Replies: 2 | Reply

Avatar Afropuffashion (< 20) Submitted: 6/21/08 1:58 AM

Recs: 0 | Rec This

There is an analyst reporter pumping this stock. The short term gain from his 5 part series on why a person should purchase this stock is unethical. The analyst is all pumps, with little regard for facts. The articles act as if the controversial drug is worry free.

Report this Post Reply

Avatar Afropuffashion (< 20) Submitted: 6/22/08 11:43 AM

Recs: 0 | Rec This

Here is the link to the series I am refering to above. Imagine the impact of a five part series on the price of a penny stock. This stock is overvalued.

http://seekingalpha.com/article/82180-mannkind-overlooked-biotech-with-excellent-prospects-part-vi?source=side_bar_long_ideas

Report this Post Reply

Featured Broker Partners